Royal Bank of Canada’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$149K Sell
6,989
-76,035
-92% -$1.58M ﹤0.01% 4896
2025
Q4
$1.77M Buy
83,024
+74,895
+921% +$1.53M ﹤0.01% 3217
2025
Q3
$137K Sell
8,129
-13,822
-63% -$207K ﹤0.01% 5323
2025
Q2
$316K Sell
21,951
-146
-0.7% -$2K ﹤0.01% 4808
2025
Q1
$320K Buy
22,097
+4,247
+24% +$60.3K ﹤0.01% 4343
2024
Q4
$234K Buy
17,850
+8,963
+101% +$124K ﹤0.01% 4681
2024
Q3
$103K Buy
8,887
+98
+1% +$924 ﹤0.01% 5325
2024
Q2
$67K Sell
8,789
-12,466
-59% -$103K ﹤0.01% 5510
2024
Q1
$213K Sell
21,255
-4,925
-19% -$45.8K ﹤0.01% 4634
2023
Q4
$244K Buy
26,180
+10,971
+72% +$113K ﹤0.01% 4929
2023
Q3
$193K Buy
15,209
+5,826
+62% +$80K ﹤0.01% 4839
2023
Q2
$133K Buy
9,383
+4,203
+81% +$59K ﹤0.01% 5099
2023
Q1
$76K Sell
5,180
-6,821
-57% -$103K ﹤0.01% 5378
2022
Q4
$178K Buy
12,001
+9,835
+454% +$160K ﹤0.01% 4972
2022
Q3
$35K Buy
2,166
+1,068
+97% +$21.5K ﹤0.01% 5915
2022
Q2
$23K Sell
1,098
-4,267
-80% -$87.1K ﹤0.01% 6042
2022
Q1
$126K Sell
5,365
-7,265
-58% -$178K ﹤0.01% 5473
2021
Q4
$343K Buy
12,630
+2,942
+30% +$78.8K ﹤0.01% 4812
2021
Q3
$275K Buy
9,688
+3,496
+56% +$107K ﹤0.01% 4872
2021
Q2
$187K Buy
6,192
+4,119
+199% +$122K ﹤0.01% 5133
2021
Q1
$53K Sell
2,073
-40,305
-95% -$1.03M ﹤0.01% 5843
2020
Q4
$1.04M Buy
42,378
+31,798
+301% +$597K ﹤0.01% 3452
2020
Q3
$172K Buy
10,580
+5,896
+126% +$110K ﹤0.01% 4645
2020
Q2
$80K Sell
4,684
-125,895
-96% -$1.87M ﹤0.01% 4986
2020
Q1
$1.52M Buy
130,579
+63,395
+94% +$1.31M ﹤0.01% 2695
2019
Q4
$1.87M Buy
67,184
+53,393
+387% +$1.34M ﹤0.01% 2929
2019
Q3
$313K Sell
13,791
-22,199
-62% -$506K ﹤0.01% 4149
2019
Q2
$907K Sell
35,990
-1,704
-5% -$45.8K ﹤0.01% 3385
2019
Q1
$1.02M Sell
37,694
-32,213
-46% -$1.08M ﹤0.01% 3172
2018
Q4
$2.31M Sell
69,907
-26,708
-28% -$1.07M ﹤0.01% 2546
2018
Q3
$4.51M Buy
96,615
+52,610
+120% +$2.42M ﹤0.01% 2191
2018
Q2
$1.91M Buy
44,005
+3,402
+8% +$163K ﹤0.01% 2765
2018
Q1
$2.26M Buy
40,603
+8,692
+27% +$476K ﹤0.01% 2596
2017
Q4
$1.71M Sell
31,911
-2,957
-8% -$140K ﹤0.01% 2864
2017
Q3
$1.5M Buy
34,868
+4,488
+15% +$213K ﹤0.01% 2894
2017
Q2
$1.83M Sell
30,380
-97,350
-76% -$5.77M ﹤0.01% 2656
2017
Q1
$8.86M Buy
127,730
+9,121
+8% +$634K ﹤0.01% 1554
2016
Q4
$7.91M Buy
118,609
+14,760
+14% +$960K ﹤0.01% 1656
2016
Q3
$6.88M Sell
103,849
-67,975
-40% -$4.65M ﹤0.01% 1707
2016
Q2
$12.4M Sell
171,824
-13,587
-7% -$934K 0.01% 1300
2016
Q1
$12M Buy
185,411
+24,326
+15% +$1.61M 0.01% 1279
2015
Q4
$11.5M Buy
161,085
+131,032
+436% +$9.69M 0.01% 1340
2015
Q3
$2.31M Sell
30,053
-23,543
-44% -$1.9M ﹤0.01% 2151
2015
Q2
$3.97M Sell
53,596
-10,536
-16% -$758K ﹤0.01% 1768
2015
Q1
$4.65M Sell
64,132
-279,871
-81% -$19.5M ﹤0.01% 1655
2014
Q4
$22.7M Sell
344,003
-57,949
-14% -$3.54M 0.01% 779
2014
Q3
$22M Buy
401,952
+189,385
+89% +$10.7M 0.02% 747
2014
Q2
$12.4M Buy
212,567
+186,199
+706% +$11M 0.01% 1089
2014
Q1
$1.64M Sell
26,368
-8,154
-24% -$474K ﹤0.01% 2388
2013
Q4
$1.84M Sell
34,522
-8,432
-20% -$453K ﹤0.01% 2358
2013
Q3
$2.16M Buy
42,954
+13,214
+44% +$645K ﹤0.01% 2153
2013
Q2
$1.36M Buy
+29,740
New +$1.33M ﹤0.01% 2341

Other funds holding MD

Royal Bank of Canada's MD Position: Q1 2026 in Review

Royal Bank of Canada reduced its Pediatrix Medical (MD) stake by 92% in Q1 2026, selling an estimated $1.58M and leaving 6,989 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #4896.

Royal Bank of Canada first reported a position in MD in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.7M in Q4 2014. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Royal Bank of Canada held 6,989 shares of Pediatrix Medical worth $149K as of Q1 2026.
  • Royal Bank of Canada sold 76,035 Pediatrix Medical shares in Q1 2026, an estimated $1.58M.
  • Pediatrix Medical made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4896 holding.
  • Royal Bank of Canada first reported a position in Pediatrix Medical in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Pediatrix Medical position peaked at $22.7M in Q4 2014.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.